Foghorn Therapeutics Inc. (FHTX)
Since Aug 10, 2021, Foghorn Therapeutics Inc. (FHTX) has reported earnings 21 times. On average the shares move ±5.23% post-earnings, with a positive reaction 47.6% of the time. Its largest post-earnings gain was +13.93% (Aug 06, 2026) and its largest decline was -12.92% (Mar 11, 2026). The next earnings report is predicted for 2026-11-04 (estimated).
Earnings reactions
How FHTX moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±5.23%
Positive %
47.6%
Negative %
52.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☀ PRE | +13.93% | open_in_new |
| May 07, 2026 | ☀ PRE | -10.34% | open_in_new |
| Mar 11, 2026 | ☽ POST | -12.92% | open_in_new |
| Nov 05, 2025 | ☀ PRE | +13.31% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±5.23%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
Frequently asked about FHTX earnings
When does Foghorn Therapeutics Inc. report earnings next? expand_more
Foghorn Therapeutics Inc. (FHTX)'s next earnings date is estimated for 2026-11-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does FHTX stock move after earnings? expand_more
Over 21 reports, FHTX has moved an average of ±5.23% the session after earnings, closing higher 47.6% of the time.
What was FHTX's biggest post-earnings move? expand_more
FHTX's largest post-earnings gain on record was +13.93% on Aug 06, 2026, and its largest decline was -12.92% on Mar 11, 2026.
Where can I find Foghorn Therapeutics Inc.'s SEC filings? expand_more
All of Foghorn Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right